MRE11 Homolog, Double Strand Break Repair Nuclease

A key component of the MRN complex involved in DNA damage repair and telomere maintenance.

Gene Information Card

Symbol MRE11
Full Name MRE11 homolog, double strand break repair nuclease
Gene Type protein-coding
Chromosomal Location 11q21
NCBI Gene ID 4361 ncbi.nlm.nih.gov/gene/4361
Ensembl ID ENSG00000020922
UniProt ID P49959
OMIM ID 600814
HGNC ID 7230
Aliases MRE11A, ATLD, HNGS1, MRE11B

Description

MRE11 encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. The protein forms the MRN complex with RAD50 and NBN (NBS1). This complex possesses single-strand endonuclease and double-strand-specific 3'-5' exonuclease activity, critical for DNA end processing. Mutations in MRE11 cause ataxia-telangiectasia-like disorder (ATLD) and are associated with susceptibility to various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Ataxia-telangiectasia-like disorder (ATLD) Loss-of-function mutations impair DNA damage signaling and repair, leading to neurodegeneration and radiosensitivity. OMIM #604391
Breast cancer Germline and somatic MRE11 variants may disrupt homologous recombination, increasing genomic instability. ClinVar, COSMIC
Colorectal cancer Somatic mutations and altered expression of MRE11 contribute to microsatellite instability and tumor progression. COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.8 Medium
Bone marrow 10.5 Medium
Lymph node 9.2 Medium
Brain 6.1 Low
Liver 4.3 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 14.2 Cervical cancer cell line; high expression
MCF7 11.5 Breast cancer cell line; moderate expression
K562 9.8 Leukemia cell line; moderate expression
HepG2 7.3 Hepatocellular carcinoma; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1714C>T (p.Arg572Ter) Nonsense Rare Loss of function; associated with ATLD
c.1100C>T (p.Thr367Ile) Missense <0.01% Impaired nuclease activity; linked to cancer susceptibility
c.1890+1G>A Splice site Rare Aberrant splicing; loss of protein function
Mutation functional classification

Loss of Function (LOF)

Most pathogenic mutations are loss-of-function, reducing DNA repair capacity and causing genomic instability.

Gain of Function (GOF)

Not well documented; gain-of-function mutations are rare or absent in current databases.

Dominant Negative (DN)

Some missense mutations (e.g., p.Thr367Ile) may act in a dominant-negative manner by disrupting MRN complex assembly.

Gene Ontology (GO)

• double-strand break repair via homologous recombination • telomere maintenance
• DNA endonuclease activity • exonuclease activity
• protein binding • nucleus

Pathways

Homologous recombination (KEGG: hsa03440)
Non-homologous end-joining (KEGG: hsa03450)
DNA damage response (Reactome: R-HSA-5693568)

Protein Summary

MRE11 is a 708-amino acid protein with a molecular weight of ~80 kDa. It contains a nuclease domain, a DNA-binding domain, and a C-terminal region that interacts with RAD50. The protein is essential for DNA double-strand break repair, checkpoint activation, and telomere maintenance. Its nuclease activity processes DNA ends to generate 3' overhangs for homologous recombination.

Related Products

Product name Cat.No. Species Gene ID
MRE11 Knockout HEK293 Cell Line EDJ-KQ3753 Human 4361 Details Get a Quote
MRE11 Knockout A-549 Cell Line EDJ-KQ25827 Human 4361 Details Get a Quote
MRE11 Knockout HCT 116 Cell Line EDJ-KQ25828 Human 4361 Details Get a Quote
MRE11 Knockout HeLa Cell Line EDJ-KQ25829 Human 4361 Details Get a Quote
MRE11 (c.1784-66A>G )Point Mutation in HAP1 Cell Line EDC03547 Human 4361 Details Get a Quote
MRE11 (c.403-6G>A )Point Mutation in HAP1 Cell Line EDC03548 Human 4361 Details Get a Quote
MRE11 (c.20+28G>A )Point Mutation in HAP1 Cell Line EDC03549 Human 4361 Details Get a Quote
Displaying Records 1 To 7 Of 7 Records
Contact Us
*
*
*
*
How did you hear about us: